Cargando…

The Emerging Regulation of VEGFR-2 in Triple-Negative Breast Cancer

Vascular endothelial growth factor-A (VEGF) signals vascular development and angiogenesis mainly by binding to VEGF receptor family member 2 (VEGFR-2). Adaptor proteins mediate many VEGFR-2’s functions in the development of blood vessels. Cancer cells secrete VEGF to activate VEGFR-2 pathway in thei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Xiaoxia, Zhou, Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598588/ https://www.ncbi.nlm.nih.gov/pubmed/26500608 http://dx.doi.org/10.3389/fendo.2015.00159

Ejemplares similares

FAK Regulates VEGFR2 Expression and Promotes Angiogenesis in Triple-Negative Breast Cancer
por: Shiau, Jun-Ping, et al.
Publicado: (2021)

Dietary Fructose Consumption and Triple-Negative Breast Cancer Incidence
por: Strober, Jordan W., et al.
Publicado: (2019)

High VEGFR3 Expression Reduces Doxorubicin Efficacy in Triple-Negative Breast Cancer
por: Torres-Ruiz, Sandra, et al.
Publicado: (2023)

Identification of MAGEC2/CT10 as a High Calcium-Inducible Gene in Triple-Negative Breast Cancer
por: Beasley, Heather K., et al.
Publicado: (2022)

Resibufogenin Suppresses Triple-Negative Breast Cancer Angiogenesis by Blocking VEGFR2-Mediated Signaling Pathway
por: Yang, Ting, et al.
Publicado: (2021)

Single Hormone Receptor-Positive Metaplastic Breast Cancer: Similar Outcome as Triple-Negative Subtype
por: Mao, Jinqian, et al.
Publicado: (2021)

Prognostic Factors and Models for Elderly (≥70 Years Old) Primary Operable Triple-Negative Breast Cancer: Analysis From the National Cancer Database
por: Tang, Zhuowei, et al.
Publicado: (2022)

A novel conditional survival nomogram for monitoring real-time prognosis of non-metastatic triple-negative breast cancer
por: Meng, Xiangdi, et al.
Publicado: (2023)

FGA Controls VEGFA Secretion to Promote Angiogenesis by Activating the VEGFR2-FAK Signalling Pathway
por: Li, Hui, et al.
Publicado: (2022)

Down-Regulation of Toll-Like Receptor 5 (TLR5) Increased VEGFR Expression in Triple Negative Breast Cancer (TNBC) Based on Radionuclide Imaging
por: Jiang, Wen, et al.
Publicado: (2021)

Effect of surgical treatment on patients with stage T3 or T4 triple-negative breast cancer: a SEER-based retrospective observational study
por: Hu, Jie, et al.
Publicado: (2023)

A Novel Bispecific Antibody Targeting EGFR and VEGFR2 Is Effective against Triple Negative Breast Cancer via Multiple Mechanisms of Action
por: Mohan, Nishant, et al.
Publicado: (2021)

Upregulation of G Protein-Coupled Estrogen Receptor by Chrysin-Nanoparticles Inhibits Tumor Proliferation and Metastasis in Triple Negative Breast Cancer Xenograft Model
por: Kim, Kyoung Mee, et al.
Publicado: (2020)

Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer Cells
por: Michmerhuizen, Anna R., et al.
Publicado: (2020)

Immune checkpoint inhibitors in first-line therapies of metastatic or early triple-negative breast cancer: a systematic review and network meta-analysis
por: Liang, Xueyan, et al.
Publicado: (2023)

Ferroptosis: the emerging player in remodeling triple-negative breast cancer
por: Li, Jie, et al.
Publicado: (2023)

Eugenol modulates the NOD1-NF-κB signaling pathway via targeting NF-κB protein in triple-negative breast cancer cells
por: Shi, Xiaoyu, et al.
Publicado: (2023)

Nuclear Insulin-Like Growth Factor Binding Protein-3 As a Biomarker in Triple-Negative Breast Cancer Xenograft Tumors: Effect of Targeted Therapy and Comparison With Chemotherapy
por: Julovi, Sohel M., et al.
Publicado: (2018)

M2 macrophage-induced lncRNA PCAT6 facilitates tumorigenesis and angiogenesis of triple-negative breast cancer through modulation of VEGFR2
por: Dong, Fang, et al.
Publicado: (2020)

Addition of Capecitabine to Adjuvant Chemotherapy May be the Most Effective Strategy for Patients With Early-Stage Triple-Negative Breast Cancer: A Network Meta-Analysis of 9 Randomized Controlled Trials
por: Li, Zhiyang, et al.
Publicado: (2022)

ODP433 An increased in AIPB expression in Triple Negative (ER-/PR-/Her2-) Breast Tumors reduces estradiol synthesis
por: Downs, William V, et al.
Publicado: (2022)

Emerging Therapeutic Drugs in Metastatic Triple-Negative Breast Cancer
por: Cipriano, Élia, et al.
Publicado: (2021)

Emerging treatment strategies for metastatic triple-negative breast cancer
por: Huppert, Laura A., et al.
Publicado: (2022)

The Combination of the CDK4/6 Inhibitor, Palbociclib, With the Vitamin D(3) Analog, Inecalcitol, Has Potent In Vitro and In Vivo Anticancer Effects in Hormone-Sensitive Breast Cancer, But Has a More Limited Effect in Triple-Negative Breast Cancer
por: Vanhevel, Justine, et al.
Publicado: (2022)

Correction: M2 macrophage-induced lncRNA PCAT6 facilitates tumorigenesis and angiogenesis of triple-negative breast cancer through modulation of VEGFR2
por: Dong, Fang, et al.
Publicado: (2022)

Identification of MTHFD2 as a prognostic biomarker and ferroptosis regulator in triple-negative breast cancer
por: Zhang, Hao, et al.
Publicado: (2023)

Regulation of cancer stem cells in triple negative breast cancer
por: Fultang, Norman, et al.
Publicado: (2021)

Triple-Negative Breast Cancer
por: Chu, Quyen D., et al.
Publicado: (2012)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

Molecular Biology Mechanisms and Emerging Therapeutics of Triple-Negative Breast Cancer
por: Zhang, Zhiying, et al.
Publicado: (2023)

RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer
por: Li, Ming, et al.
Publicado: (2020)

21-Gene Recurrence Assay Associated With Favorable Metabolic Profiles in HR-Positive, HER2-Negative Early-Stage Breast Cancer Patients
por: Zhu, Yifei, et al.
Publicado: (2021)

Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
por: Girgert, Rainer, et al.
Publicado: (2019)

MicroRNAs in regulation of triple-negative breast cancer progression
por: Piasecka, Dominika, et al.
Publicado: (2018)

Epigenetic Regulation and Dietary Control of Triple Negative Breast Cancer
por: Selmin, Ornella I., et al.
Publicado: (2020)

Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast Cancer
por: Llinàs-Arias, Pere, et al.
Publicado: (2021)

Effects of oestradiol and tamoxifen on VEGF, soluble VEGFR-1, and VEGFR-2 in breast cancer and endothelial cells
por: Garvin, S, et al.
Publicado: (2005)

Molecular subtypes and precision treatment of triple-negative breast cancer
por: Zhao, Shen, et al.
Publicado: (2020)

Molecular Mechanisms and Emerging Therapeutic Targets of Triple-Negative Breast Cancer Metastasis
por: Neophytou, Christiana, et al.
Publicado: (2018)

Triple negative breast cancer: special histological types and emerging therapeutic methods
por: Cao, Lu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nciedblfctdl0frkhkrkvem48g